Genetic variations of NAT2 and CYP2E1 and isoniazid hepatotoxicity in a diverse population

Pharmacogenomics. 2010 Sep;11(9):1205-6; author reply 1207-8. doi: 10.2217/pgs.10.109.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Alleles
  • Antitubercular Agents / adverse effects*
  • Arylamine N-Acetyltransferase / blood*
  • Case-Control Studies
  • Chemical and Drug Induced Liver Injury / genetics*
  • Cytochrome P-450 CYP2E1 / genetics*
  • Gene Frequency
  • Genotype
  • Humans
  • Polymorphism, Genetic
  • Sample Size

Substances

  • Antitubercular Agents
  • Cytochrome P-450 CYP2E1
  • Arylamine N-Acetyltransferase
  • NAT2 protein, human